| Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ... New England Journal of Medicine 380 (1), 11-22, 2019 | 2890 | 2019 |
| Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ... European heart journal 36 (17), 1012-1022, 2015 | 1510 | 2015 |
| National lipid association recommendations for patient-centered management of dyslipidemia: part 1—full report TA Jacobson, MK Ito, KC Maki, CE Orringer, HE Bays, PH Jones, ... Journal of clinical lipidology 9 (2), 129-169, 2015 | 827 | 2015 |
| Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association DS Siscovick, TA Barringer, AM Fretts, JHY Wu, AH Lichtenstein, ... Circulation 135 (15), e867-e884, 2017 | 663 | 2017 |
| Final conclusions and recommendations of the national lipid association statin safety assessment task force JM McKenney, MH Davidson, TA Jacobson, JR Guyton The American journal of cardiology 97 (8), S89-S94, 2006 | 633 | 2006 |
| Meta-analysis of the relationship between non–high-density lipoprotein cholesterol reduction and coronary heart disease risk JG Robinson, S Wang, BJ Smith, TA Jacobson Journal of the American College of Cardiology 53 (4), 316-322, 2009 | 629 | 2009 |
| Risk for myopathy with statin therapy in high-risk patients CM Ballantyne, A Corsini, MH Davidson, H Holdaas, TA Jacobson, ... Archives of internal medicine 163 (5), 553-564, 2003 | 593 | 2003 |
| Statin safety and associated adverse events: a scientific statement from the American Heart Association CB Newman, D Preiss, JA Tobert, TA Jacobson, RL Page, LB Goldstein, ... Arteriosclerosis, thrombosis, and vascular biology 39 (2), e38-e81, 2019 | 591 | 2019 |
| National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1–executive summary TA Jacobson, MK Ito, KC Maki, CE Orringer, HE Bays, PH Jones, ... Journal of clinical lipidology 8 (5), 473-488, 2014 | 589 | 2014 |
| National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2 TA Jacobson, KC Maki, CE Orringer, PH Jones, P Kris-Etherton, G Sikand, ... Journal of clinical lipidology 9 (6), S1-S122. e1, 2015 | 575 | 2015 |
| An assessment by the statin muscle safety task force: 2014 update RS Rosenson, SK Baker, TA Jacobson, SL Kopecky, BA Parker Journal of clinical lipidology 8 (3), S58-S71, 2014 | 554 | 2014 |
| Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users JD Cohen, EA Brinton, MK Ito, TA Jacobson Journal of clinical lipidology 6 (3), 208-215, 2012 | 535 | 2012 |
| Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: the ODYSSEY ALTERNATIVE randomized trial PM Moriarty, PD Thompson, CP Cannon, JR Guyton, J Bergeron, FJ Zieve, ... Journal of clinical lipidology 9 (6), 758-769, 2015 | 527 | 2015 |
| Safety considerations with fibrate therapy MH Davidson, A Armani, JM McKenney, TA Jacobson The American journal of cardiology 99 (6), S3-S18, 2007 | 494 | 2007 |
| Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease S Kripalani, J Risser, ME Gatti, TA Jacobson Value in Health 12 (1), 118-123, 2009 | 464 | 2009 |
| Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review TA Jacobson, SB Glickstein, JD Rowe, PN Soni Journal of clinical lipidology 6 (1), 5-18, 2012 | 451 | 2012 |
| Use of Lipoprotein (a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association DP Wilson, TA Jacobson, PH Jones, ML Koschinsky, CJ McNeal, ... Journal of clinical lipidology 13 (3), 374-392, 2019 | 436 | 2019 |
| Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists MH Davidson, CM Ballantyne, TA Jacobson, VA Bittner, LT Braun, ... Journal of clinical lipidology 5 (5), 338-367, 2011 | 436 | 2011 |
| Adverse effects of statin therapy: perception vs. the evidence–focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract F Mach, KK Ray, O Wiklund, A Corsini, AL Catapano, E Bruckert, ... European heart journal 39 (27), 2526-2539, 2018 | 395 | 2018 |
| Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association AC Skulas-Ray, PWF Wilson, WS Harris, EA Brinton, PM Kris-Etherton, ... Circulation 140 (12), e673-e691, 2019 | 394 | 2019 |
